Suppr超能文献

β-胡萝卜素对多种抗癌药物的体内调节作用。

In vivo modulation of several anticancer agents by beta-carotene.

作者信息

Teicher B A, Schwartz J L, Holden S A, Ara G, Northey D

机构信息

Dana-Farber Cancer Institute, Boston, MA 02115.

出版信息

Cancer Chemother Pharmacol. 1994;34(3):235-41. doi: 10.1007/BF00685083.

Abstract

The ability of the collagenase inhibitor minocycline and of beta-carotene to act as positive modulators of cytotoxic anticancer agents was assessed in vitro and in vivo. Cell-culture studies were conducted using the human SCC-25 squamous carcinoma cell line. Simultaneous exposure of the cells to minocycline and beta-carotene or 13-cis-retinoic acid along with cisplatin (CDDP) resulted in a small decrease in the cytotoxicity of the CDDP. The addition of each of the modulator combinations for 1 h or 24 h to treatment with melphalan (L-PAM) or carmustine (BCNU) resulted in greater-than-additive cytotoxicity with each of four regimens. The modulator combinations of minocycline and beta-carotene applied for 1 h or 24 h and the modulator combination of minocycline and 13-cis-retinoic acid produced greater-than-additive cytotoxicity at 50 microM 4-hydroperoxycyclophosphamide (4-HC), whereas minocycline and 13-cis-retinoic acid applied for 1 h was antagonistic with 4-HC and the other modulator treatments at low concentrations of 4-HC resulted in subadditive cytotoxicity. The effect of treatment with beta-carotene alone and in combination with several different anticancer agents was examined in two murine solid tumors, the FSaII fibrosarcoma and the SCC VII carcinoma. Administration of the modulators alone or in combination did not alter the growth of either tumor. Whereas increases in tumor growth delay occurred with the antitumor alkylating agents and beta-carotene and with minocycline and beta-carotene, a diminution in tumor growth delay was produced by 5-fluorouracil in the presence of these modulators. The modulator combination also resulted in increased tumor growth delay with adriamycin and etoposide. Tumor-cell survival assay showed increased killing of FSaII tumor cells with the modulator combination and melphalan or cyclophosphamide as compared with the drugs alone. These results indicate that further investigation of this modulator strategy is warranted.

摘要

在体外和体内评估了胶原酶抑制剂米诺环素和β-胡萝卜素作为细胞毒性抗癌药物正调节剂的能力。使用人SCC - 25鳞状癌细胞系进行细胞培养研究。将细胞同时暴露于米诺环素、β-胡萝卜素或13 - 顺式视黄酸以及顺铂(CDDP)中,导致CDDP的细胞毒性略有降低。在使用美法仑(L - PAM)或卡莫司汀(BCNU)治疗时,添加每种调节剂组合1小时或24小时,在四种治疗方案中均产生了大于相加的细胞毒性。米诺环素和β-胡萝卜素的调节剂组合应用1小时或24小时,以及米诺环素和13 - 顺式视黄酸的调节剂组合在50微摩尔4 - 氢过氧环磷酰胺(4 - HC)时产生了大于相加的细胞毒性,而米诺环素和13 - 顺式视黄酸应用1小时在低浓度4 - HC时与4 - HC拮抗,其他调节剂处理导致亚相加细胞毒性。在两种小鼠实体瘤FSaII纤维肉瘤和SCC VII癌中研究了单独使用β-胡萝卜素以及与几种不同抗癌药物联合使用的效果。单独或联合给予调节剂均未改变任何一种肿瘤的生长。虽然抗肿瘤烷化剂与β-胡萝卜素以及米诺环素与β-胡萝卜素联合使用时肿瘤生长延迟增加,但在这些调节剂存在的情况下,5 - 氟尿嘧啶会导致肿瘤生长延迟减少。调节剂组合与阿霉素和依托泊苷联合使用也导致肿瘤生长延迟增加。肿瘤细胞存活试验表明,与单独使用药物相比,调节剂组合与美法仑或环磷酰胺联合使用时对FSaII肿瘤细胞的杀伤增加。这些结果表明有必要对这种调节剂策略进行进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验